Nano-X Imaging (NASDAQ:NNOX) Given Overweight Rating at Cantor Fitzgerald

Posted by Geri Gentry on Aug 17th, 2026

Nano-X Imaging (NASDAQ:NNOX – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a research note issued to investors on Monday,Benzinga reports. They currently have a $5.00 target price on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 401.15% from the company’s previous close.

Several other equities analysts also recently weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. Alliance Global Partners cut Nano-X Imaging from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $5.00 to $3.00 in a research report on Tuesday, July 7th. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a research note on Monday, April 20th. Finally, Zacks Research raised Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $4.33.

Read Our Latest Stock Report on NNOX

Nano-X Imaging Stock Performance

NNOX opened at $1.00 on Monday. The firm’s 50 day simple moving average is $1.23 and its two-hundred day simple moving average is $1.89. The company has a market capitalization of $69.90 million, a PE ratio of -0.63 and a beta of 1.27. Nano-X Imaging has a 1-year low of $0.73 and a 1-year high of $4.71.

Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last issued its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. Equities analysts forecast that Nano-X Imaging will post -0.6 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Erez Meltzer acquired 36,000 shares of Nano-X Imaging stock in a transaction dated Monday, July 27th. The shares were purchased at an average price of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the transaction, the chief executive officer directly owned 36,000 shares in the company, valued at approximately $33,480. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Dan S. Suesskind purchased 50,000 shares of Nano-X Imaging stock in a transaction on Monday, July 27th. The stock was bought at an average price of $0.93 per share, for a total transaction of $46,500.00. Following the completion of the acquisition, the director owned 50,000 shares in the company, valued at $46,500. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have acquired 95,443 shares of company stock valued at $89,706.

Hedge Funds Weigh In On Nano-X Imaging

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Kestra Advisory Services LLC bought a new position in shares of Nano-X Imaging in the 1st quarter valued at about $26,000. Independent Financial Group LLC purchased a new stake in Nano-X Imaging during the first quarter valued at approximately $26,000. Interchange Capital Partners LLC purchased a new stake in Nano-X Imaging during the fourth quarter valued at approximately $28,000. Aristides Capital LLC bought a new stake in shares of Nano-X Imaging in the 4th quarter valued at approximately $30,000. Finally, Hsbc Holdings PLC bought a new stake in shares of Nano-X Imaging in the 1st quarter valued at approximately $35,000. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.